CSL profits jump 44 per cent on vaccine demand
SYDNEY: CSL chief executive Paul Perreault has warned the outlook for plasma collections remains challenging
SYDNEY: CSL chief executive Paul Perreault has warned the outlook for plasma collections remains challenging